Herpes virus infections amongst moderate to severe atopic dermatitis patients treated with baricitinib: an integrated analysis of phase 3 trials

被引：0
|
作者：
Werfel, T. [1 ]
Irvine, A. D. [2 ]
Bangert, C. [3 ]
Seneschal, J. [4 ]
Grond, S. [5 ]
Cardillo, T. [5 ]
Brinker, D. [5 ]
Zhong, J. [6 ]
Riedl, E. [5 ]
Wollenberg, A. [7 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Trinity Coll Dublin, Dublin, Ireland
[3] Med Univ Vienna, Vienna, Austria
[4] Hop St Andre, Bordeaux, France
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] IQVIA, Durham, NC USA
[7] Ludwig Maximillian Univ, Munich, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
084
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [1] Herpes virus infections amongst moderate-to-severe atopic dermatitis patients treated with baricitinib: an integrated analysis of Phase 3 trials
    Werfel, Thomas
    Irvine, Alan D.
    Bangert, Christine
    Seneschal, Julien
    Grond, Susanne
    Cardillo, Tracy
    Brinker, Dennis
    Zhong, Jinglin
    Riedl, Elisabeth
    Wollenberg, Andreas
    Truong, David
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 51 - 52
  • [2] An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis
    Werfel, T.
    Irvine, A. D.
    Bangert, C.
    Seneschal, J.
    Grond, S.
    Cardillo, T.
    Brinker, D.
    Zhong, J.
    Riedl, E.
    Wollenberg, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (09) : 1486 - 1496
  • [3] Selected infection topics in adult patients with moderate-to-severe atopic dermatitis treated with baricitinib
    Gooderham, Melinda
    Weisman, Jamie
    Goldblum, Orin
    Brinker, Dennis
    Issa, Maher
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB77 - AB77
  • [4] Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis
    Paller, Amy
    Chu, Chia-Yu
    Yang, Chin-Yi
    Janes, Jonathan
    Prakash, Apurva
    Rueda, Maria Jose
    Stanley, Sarah
    Wu, Wen-Shuo
    Zhang, Xin
    Eichenfield, Lawrence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB108 - AB108
  • [5] Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Thaci, Diamant
    Irvine, Alan D.
    Gold, Linda Stein
    Blauvelt, Andrew
    Simpson, Eric L.
    Chu, Chia-Yu
    Liu, Zhuqing
    Lima, Renata Gontijo
    Pillai, Sreekumar G.
    Seneschal, Julien
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (12): : 1080 - 1091
  • [6] An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis
    Mendes, Jocelyn T.
    Balogh, Esther A.
    Strowd, Lindsay C.
    Feldman, Steven R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1027 - 1033
  • [7] Herpes Zoster in Patients with Moderate to Severe Rheumatoid Arthritis Treated with Baricitinib
    Winthrop, Kevin L.
    Lindsey, Stephen
    Weinblatt, Michael
    Takeuchi, Tsutomu
    Hyslop, David
    Issa, Maher
    Chen, Lei
    Bradley, John
    Dickson, Christina
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
    Guttman-Yassky, Emma
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Weidinger, Stephan
    Hong, H. Chih-ho
    Hendrickson, Barbara
    Dilley, Deanne
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Irvine, Alan D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) : 172 - 181
  • [9] Efficacy of baricitinib 4 mg in patients with moderate-to-severe atopic dermatitis previously treated with systemic therapy
    Costanzo, Antonio
    Tanaka, Akio
    Torres, Tiago
    Perez-Garcia, Bibiana
    Sontag, Angelina
    Chen, Yun-Fei
    Yang, Fan Emily
    Kolodsick, Jill
    Torisu-Itakura, Hitoe
    Somani, Najwa
    JEADV CLINICAL PRACTICE, 2023, 2 (03): : 583 - 589
  • [10] Herpes simplex and eczema herpeticum in moderate to severe atopic dermatitis treated with abrocitinib
    Tyring, S.
    Feldman, S. R.
    Winthrop, K.
    Alderfer, J.
    Romero, W.
    Johnson, S.
    Fan, H.
    Valdez, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S54 - S54
12345